Xtx Topco LTD Kazia Therapeutics LTD Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Xtx Topco LTD holds 23,395 shares of KZIA stock, worth $31,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,395Holding current value
$31,583% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding KZIA
# of Institutions
19Shares Held
2.12MCall Options Held
93.2KPut Options Held
0-
Mai Capital Management1.36MShares$1.84 Million0.01% of portfolio
-
Ubs Group Ag249KShares$336,7600.0% of portfolio
-
Morgan Stanley New York, NY220KShares$297,3520.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il60.5KShares$81,6420.0% of portfolio
-
Jane Street Group, LLC New York, NY46.1KShares$62,2480.0% of portfolio
About KAZIA THERAPEUTICS LTD
- Ticker KZIA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,111,300
- Market Cap $20.4M
- Description
- Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...